Abeona Therapeutics Financials - Benzinga

Abeona Therapeutics Inc

ABEONASDAQ

Trade with Public

Trade with Public

$5.13

-0.16-3.02%

最終更新: Sep 29, 12:11 PM

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Abeona Therapeutics Financials

Abeona Therapeutics (ABEO) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Abeona Therapeutics Q2 EPS $(0.35) Misses $(0.23) Estimate, Sales $11.380M Miss $12.239M Estimate

Abeona Therapeutics (NASDAQ:ABEO) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.23) by 52.17 percent. This is a 5.41 percent increase over losses of $(0.37) per share

Benzinga Newsdesk

PRO
Abeona Therapeutics Q1 EPS $(0.30) Beats $(0.35) Estimate, Sales $8.720M Beat $4.572M Estimate

Abeona Therapeutics (NASDAQ:ABEO) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.35) by 14.29 percent. This is a 25 percent decrease over losses of $(0.24) per share from

Benzinga Newsdesk

Earnings Scheduled For May 13, 2026

Benzinga Insights

PRO
Abeona Therapeutics Q4 EPS $(0.34) Beats $(0.36) Estimate, Sales $5.420M Beat $5.270M Estimate

Abeona Therapeutics (NASDAQ:ABEO) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.36) by 4.49 percent. This is a 142.86 percent decrease over losses of $(0.14) per share

Benzinga Newsdesk

Earnings Scheduled For March 17, 2026

Benzinga Insights

PRO
Abeona Therapeutics Q3 EPS $(0.10) Beats $(0.29) Estimate

Abeona Therapeutics (NASDAQ:ABEO) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.29) by 65.52 percent. This is a 84.13 percent increase over losses of $(0.63) per share

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved